Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1630
    -0.0054 (-0.46%)
     
  • GBP/USD

    1.2386
    -0.0052 (-0.42%)
     
  • Bitcoin GBP

    51,857.63
    +573.69 (+1.12%)
     
  • CMC Crypto 200

    1,334.09
    +21.47 (+1.59%)
     
  • S&P 500

    4,982.51
    -28.61 (-0.57%)
     
  • DOW

    37,950.30
    +174.92 (+0.46%)
     
  • CRUDE OIL

    83.13
    +0.40 (+0.48%)
     
  • GOLD FUTURES

    2,409.90
    +11.90 (+0.50%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Kite Pharma Cancer Treatment Stands Out In Hot CAR-T Field

Kite Pharma Cancer Treatment Stands Out In Hot CAR-T Field

Gilead's new Kite Pharma unit is a leader in cutting-edge CAR-T therapy that fights cancer by rebuilding a patient's cells. Here's how its treatment stands out and who it helps.